SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-064759
Filing Date
2020-05-21
Accepted
2020-05-21 16:13:28
Documents
3
Period of Report
2020-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020394-1_8k.htm 8-K 35854
2 EXHIBIT 10.1 tm2020394d1_ex10-1.htm EX-10.1 109480
3 EXHIBIT 10.2 tm2020394d1_ex10-2.htm EX-10.2 123622
  Complete submission text file 0001104659-20-064759.txt   270222
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 20902000
SIC: 2834 Pharmaceutical Preparations